ÂÜÀòÂÒÂ×

Carrie Pedeferri has extensive experience in the biopharmaceutical industry, with a focus on manufacturing and quality operations. Carrie is currently the Executive Director of Manufacturing at Capsida Biotherapeutics since March 2021. Previously, they held roles at Kite Pharma, starting in August 2016, where they served as the Sr Director of Clinical Manufacturing from February 2019 to March 2021. Carrie also worked as the Director of Clinical Manufacturing from March 2017 to February 2019 and as the Director of Quality Operations from August 2016 to March 2017. Prior to Kite Pharma, they worked at Baxalta from October 2015 to July 2016, where they managed the CMO lifecycle of bulk drug substance programs. Carrie was responsible for site selection, technology transfer, manufacturing, and decommissioning, as well as leading contract negotiations and managing relationships between Baxalta and CMOs/partners. At Amgen, they held various roles from the year 2000, including Director of Global Operations Leader from 2007 to 2014, where they led a cross-functional team managing the end-to-end supply chain of a commercial product. Carrie was also the Director of Commercial Bulk Manufacturing from 2003 to 2007, leading a large manufacturing organization, and served as a Compliance Specialist from 2000 to 2003, overseeing compliance activities for multiple products and managing regulatory inspections.

Carrie Pedeferri holds a Bachelor of Science (BS) degree in Cellular and Molecular Biology from the University of Washington. The exact start and end years of their education are not provided.